Citadel Enterprise Americas key facts
- Citadel Enterprise Americas is a hedge fund based in Miami, United States with 2 tracked portfolio companies.
- Notable positions include Neuron23, Ambagon Therapeutics.
- The team roster lists 9 people.
About Citadel Enterprise Americas
Founded in 1990
Citadel Enterprise Americas portfolio at a glance
2 portfolio companies are on record for Citadel Enterprise Americas: Neuron23 and Ambagon Therapeutics.
Citadel Enterprise Americas team
9 people are on record at Citadel Enterprise Americas: 3 partners, 1 principal and 5 others. Senior names include James Yeh, Kenneth Griffin (Founder) and Pablo Salame (Co-Chief Investment Officer). 9 of them have a verified direct contact on file.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
Free account
See more of the book
- ·Watchlist + alerts for Citadel Enterprise Americas's activity
Portfolio
2 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Neuron23 | — | ▮ | ▮ | ▮ |
| Ambagon Therapeutics | Drug Discovery | ▮ | ▮ | ▮ |
All 2 companies — valuations, dates and lead flags are a member feature Membership and data by Private Market View | ||||
Team
9 people on record — 9 with verified contacts
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked about Citadel Enterprise Americas
- What companies does Citadel Enterprise Americas invest in?
- Citadel Enterprise Americas has 2 recorded portfolio companies, including Neuron23, Ambagon Therapeutics.